KENNEY CHRISTOPHER JOHN

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
2 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 22%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
KENNEY CHRISTOPHER JOHN's trades of Xenon Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
35.01
Quantity 700 -100.0%
Value US$24,507
Transaction date
Purchase
Price
28.81
Quantity 700 +inf%
Value US$20,167
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-31 2026-08-28
PlS Planned sale
87,352 -0.7%
228.62
US$2,675,677 		87,352 -0.7% 228.62 US$2,675,677
2026-08-31 2026-08-28
PlS Planned sale
32,949 -29.5%
281.68
US$2,112,082 		32,949 -29.5% 281.68 US$2,112,082
2026-08-28 2026-08-28
PrS Proposed sale
72,990
157.39
US$4,250,974 		72,990 157.39 US$4,250,974
2026-03-13 2026-03-13
PlS Planned sale
1,410 -16.6%
55.23
US$77,867 		1,410 -16.6% 55.23 US$77,867
2026-03-13 2026-03-13
PrS Proposed sale
1,410
55.22
US$77,867 		1,410 55.22 US$77,867
2026-03-11 2026-03-10
PlS Planned sale
2,771 -36.9%
60.11
US$166,559 		2,771 -36.9% 60.11 US$166,559
2026-03-10 2026-03-10
PrS Proposed sale
2,771
60.11
US$166,559 		2,771 60.11 US$166,559
2023-03-24 2023-03-24
S Sale
700 -100.0%
35.01
US$24,507 		700 -100.0% 35.01 US$24,507
2022-01-21 2022-01-21
B Purchase
700 +inf%
28.81
US$20,167 		700 +inf% 28.81 US$20,167